SANA Sana Biotechnology, Inc.
Sana Biotechnology, Inc. (SANA) is expected to report earnings on November 9, 2026, after the market close. The consensus earnings estimate is a loss of $0.17 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -2.7% since its last earnings release on August 10, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Sana Biotechnology, Inc.
Sana Biotechnology Inc. is focused on creating and delivering engineered cells as medicines for patients. The company involved in repairing and controlling genes, replacing missing or damaged cells as well as making its therapies. Sana Biotechnology Inc. is based in SEATTLE.
Sector
Healthcare
Industry
Biotechnology